EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses

Michela Falqui, Beatriz Perdiguero, Rocio Coloma, Manuel Albert, Laura Marcos-Villar, Joseph Patrick McGrail, Carlos Óscar S Sorzano, Mariano Esteban, Carmen Elena Gómez, Susana Guerra

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1187193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Michela Falqui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: HIV-1, Interferon Type I. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human immunodeficiency virus (HIV), responsible of the Acquired Immune Deficiency Syndrome (AIDS), continues to be a major global public health issue with any cure or vaccine available. The Interferon-stimulated gene 15 (ISG15) encodes a ubiquitin-like protein that is induced by interferons and plays a critical role in the immune response. ISG15 is a modifier protein that covalently binds to its targets via a reversible bond, a process known as ISGylation, which is the best-characterized activity of this protein to date. However, ISG15 can also interact with intracellular proteins via non-covalent binding or act as a cytokine in the extracellular space after secretion. In previous studies we proved the adjuvant effect of ISG15 when delivered by a DNA-vector in heterologous prime-boost combination with a Modified Vaccinia virus Ankara (MVA)-based recombinant virus expressing HIV-1 antigens Env/Gag-Pol-Nef (MVA-B). Here we extended these results evaluating the adjuvant effect of ISG15 when expressed by an MVA vector. For this, we generated and characterized two novel MVA recombinants expressing different forms of ISG15, the wild-type ISG15GG (able to perform ISGylation) or the mutated ISG15AA (unable to perform ISGylation). In mice immunized with the heterologous DNA prime/MVA boost regimen, the expression of the mutant ISG15AA from MVA-Δ3-ISG15AA vector in combination with MVA-B induced an increase in the magnitude and quality of HIV-1-specific CD8 T cells as well as in the levels of IFN-I released, providing a better immunostimulatory activity than the wild-type ISG15GG. Our results confirm the importance of ISG15 as an immune adjuvant in the vaccine field and highlights its role as a potential relevant component in HIV-1 immunization protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Interferon Type IHumansAnimalsMiceVaccinia virusAdjuvants, ImmunologicCD8-Positive T-LymphocytesImmunityUbiquitinsCytokines

Stichwörter der Autor:innen

HIVIFNISG15Modify Vaccinia virus Ankaraadjuvantinmunityvaccine

Substanzen

Interferon Type IAdjuvants, ImmunologicISG15 protein, humanUbiquitinsCytokines

Autor:innen und Institutionen

  • Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.
  • Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Biocomputing Unit and Computational Genomics, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Zitieren

APA

Falqui, M., Perdiguero, B., Coloma, R., Albert, M., Marcos-Villar, L., McGrail, J. P., Sorzano, C. Ó. S., Esteban, M., Gómez, C. E., & Guerra, S. (2023). An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1187193

Vancouver

Falqui M, Perdiguero B, Coloma R, Albert M, Marcos-Villar L, McGrail JP, et al. An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1187193

BibTeX
@article{Falqui2023,
  author = {Falqui, Michela and Perdiguero, Beatriz and Coloma, Rocio and Albert, Manuel and Marcos-Villar, Laura and McGrail, Joseph Patrick and Sorzano, Carlos Óscar S and Esteban, Mariano and Gómez, Carmen Elena and Guerra, Susana},
  title = {An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1187193}
}
Kostenlos starten →